Levi & Korsinsky is investigating potential claims on behalf of purchasers of BioSante Pharmaceuticals, Inc. (“BioSante” or the “Company”) (Nasdaq: BPAX) securities concerning possible violations of federal securities laws. For more information, click here: http://zlk.9nl.com/biosante-pharmaceuticals-bpax. The investigation stems from allegations that BioSante issued materially false and misleading statements designed to artificially inflate the Company’s stock price. In particular, the investigation concerns allegations that senior officials at BioSante misled investors about the commercial viability and effectiveness of LibiGel, an experimental compound intended to boost women’s libido. On December 14, 2011, the Company disclosed that its product LibiGel failed to yield positive results in efficacy tests. Upon this news, shares of BioSante stock plummeted from a trading high of $2.65 on December 14, 2011 to a close of $0.48 on December 15, 2011. If you own BioSante stock and wish to obtain additional information about the investigation and your legal rights, please contact Joseph E. Levi, Esq. either via email at email@example.com or by telephone at (212) 363-7500, toll-free: (877) 363-5972, or visit http://www.zlk.com/biosante-pharmaceuticals-bpax.html. Levi & Korsinsky has expertise in prosecuting investor securities litigation and extensive experience in actions involving financial fraud and represents investors throughout the nation, concentrating its practice in securities and shareholder litigation. Attorney advertising. Prior results do not guarantee similar outcomes.
More from Press Releases
NFL Pushes for Regulation Following Supreme Court's Sports Gambling Ruling
The Supreme Court rules that previous congressional action forbidding states from legalizing sports betting was unconstitutional.
Walmart CEO: 'We Are Transforming Globally' With Flipkart
On its investor call on Wednesday morning, Walmart discusses the Flipkart deal.
March 24 Full-Day Course Offering: Professional Approach to Trading SPX
OptionsProfits, the CBOE, and Option Pit are hosting a class on March 24 that covers a wide variety of methods to trade the S&P 500.